The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...
GlaxoSmithKline is investing in artificial ... It has entered into an alliance with Exscientia, a new UK company which has developed its own AI platform, and says it is at the forefront this ...
The company reported top-line data from the study earlier this year, without sharing detailed results. It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and ...